Source link : https://www.newshealth.biz/health-news/novel-agent-effective-for-cancer-wasting-disorder/
Patients with cancer cachexia and an elevated level of growth differentiation factor 15 (GDF-15) achieved significant increases in body weight with investigational ponsegromab, as well as other improvements, a randomized dose-ranging phase II study found. At 12 weeks, the placebo-adjusted median weight increase with the highest dose of the GDF-15 inhibitor reached 3.00 kg (95% […]
Author : News Health
Publish date : 2024-09-18 18:59:30
Copyright for syndicated content belongs to the linked Source.